fashion -WSS

fashion

author：Wikipedia 2025-09-14 10:04:13 - browse：5396

Sen. Bob Menendez (D-N.J.) Michael M. Santiago/Getty Images

WASHINGTON — With mounting calls for embattled Sen. Bob Menendez to resign, the pharmaceutical industry could see one of its historical, and increasingly rare, Democratic allies ousted from Congress.

The New Jersey senator is embroiled in another financial scandal after last week’s indictment over hundreds of thousands of dollars he and his wife allegedly accepted to influence military aid. The charges — which Menendez insists he will beat — come roughly seven years after he was accused of pressuring Medicare officials to resolve a dispute in favor of a lavish political donor. That case ended in a hung jury.

But this time around, Capitol lawmakers and New Jersey Democrats including Sen. Cory Booker, a longtime legislation partner, are calling on Menendez to resign. The mounting pressure and looming court battle spell out a hazy future for one of the pharmaceutical industry’s biggest allies in the Democratic Party.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Departing Stanford president retracts two papers

WSS

Unicorn down: Following layoffs, Biofourmis CEO quietly departs

Departing Stanford president retracts two papers

Who gets to use the title 'doctor'?

Winners, losers from Medicare’s list of drugs subject to price talks

In science, is the line between industry and academia shifting?

J&J expands global access to TB drug amid advocacy campaign

explore

fashion

hotspot

Jerome Adams on the need for new antivirals for Covid

Why more medical students aren't specializing in primary care

Hepatitis C has a cure — but many Americans still lack access to it

Celiac disease study examines precisely how gluten triggers injury

ChatGPT in medicine: STAT answers readers' burning questions

Medicare eyes cuts to doctors, raises to outpatient clinics in 2024

FDA approval of Sarepta Duchenne genetic therapy gives me hope

As pharma fights Medicare drug negotiation, hospitals, docs silent

At least 13 dead in Texas as scorching temps continue

Argenx drug significantly slows progression of nerve disorder

hotspot

Elon Musk says Twitter has 'negative cash flow' and 'heavy debt'

Winners, losers from Medicare’s list of drugs subject to price talks

Everything to know for the next Powerball drawing as jackpot hits $1 billion

Eli Lilly to acquire Versanis in heated race for weight loss drugs

How a symptom of dementia informs our understanding of creativity

Involuntary treatment for addiction doesn't work

Wikipedia

explore

Wikipedia

knowledge